Investing.com Jan 06, 2026 FDA approves Celltrion’s 300mg strength OMLYCLO biosimilar The U.S. Food and Drug Administration approved a new 300mg/2mL strength of OMLYCLO (omalizumab-igec), Celltrion’s ...

Kaiju No. 8 THE GAME has launched a half-anniversary event that adds new story content, playable characters and large-scale in-game rewards, publisher Akatsuki Games announced Monday. The update ...

FDA approval of Filkri expands Accord’s G-CSF biosimilar portfolio, offering a short-acting option for neutropenia in cancer care.

Inven Global is your top-tier choice for authentic esports news, articles, opinions and strategy. From East to West, our esports coverage is written by gamers for gamers.